Eotaxin-CCR3 interaction promotes survival of anaplastic large cell lymphoma cells via ERK1/2 activation

被引：0
|
作者：
Miyagaki, T. [1 ]
Sugaya, M. [1 ]
Kadono, T. [1 ]
Murakami, T. [2 ]
Okochi, H. [3 ]
Tamaki, K. [1 ]
Sato, S. [1 ]
机构：
[1] Univ Tokyo, Dept Dermatol, Tokyo 113, Japan
[2] Jichi Med Univ, Div Bioimaging Sci, Ctr Mol Med, Tochigi, Japan
[3] Ctr Internal Med, Dept Regenerat Med, Res Inst, Tokyo, Japan
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
583
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [41] Activation of PAR2 or/and TLR4 promotes SW620 cell proliferation and migration via phosphorylation of ERK1/2
    Zhou, Baocheng
    Zhou, Hong
    Ling, Shucai
    Guo, Donglin
    Yan, Yihong
    Zhou, Fang
    Wu, Ying
    ONCOLOGY REPORTS, 2011, 25 (02) : 503 - 511
  • [42] JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis
    Le, Kang
    Wellik, Linda E.
    Maurer, Matthew J.
    McPhail, Ellen D.
    Witzig, Thomas E.
    Gupta, Mamta
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [43] JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis
    Kang Le
    Linda E. Wellik
    Matthew J. Maurer
    Ellen D. McPhail
    Thomas E. Witzig
    Mamta Gupta
    Blood Cancer Journal, 11
  • [44] ACTIVATION OF MTORC2 COMPLEX CONTRIBUTES TO CELL CYCLE PROGRESSION AND SURVIVAL IN ALK plus ANAPLASTIC LARGE CELL LYMPHOMA
    Rassidakis, G.
    Tsesmetzis, N.
    Chioureas, D.
    Baltatzis, G.
    Atsaves, V.
    Leventaki, V.
    Panaretakis, T.
    Drakos, E.
    HAEMATOLOGICA, 2016, 101 : 568 - 569
  • [45] Y-Box Protein 1 Stimulates Mesangial Cell Proliferation via Activation of ERK1/2
    Feng, Quancheng
    Huang, Songming
    Zhang, Aihua
    Chen, Qiuxia
    Guo, Xirong
    Chen, Ronghua
    Yang, Tianxin
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2009, 113 (01): : E16 - E25
  • [46] Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells
    Qiu, Lin
    Lai, Raymond
    Lin, Quan
    Lau, Esther
    Thomazy, David M.
    Calame, Daniel
    Ford, Richard J.
    Kwak, Larry W.
    Kirken, Robert A.
    Amin, Hesham M.
    BLOOD, 2006, 108 (07) : 2407 - 2415
  • [47] Clemastine Promotes Differentiation of Oligodendrocyte Progenitor Cells Through the Activation of ERK1/2 via Muscarinic Receptors After Spinal Cord Injury
    Tong, Lu-Yao
    Deng, Yong-Bing
    Du, Wei-Hong
    Zhou, Wen-Zhu
    Liao, Xin-Yu
    Jiang, Xue
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1/2 pathway
    Ji, Wenbin
    Chen, Jin
    Mi, Yucheng
    Wang, Guanliang
    Xu, Xinjian
    Wang, Weizhen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (01) : 181 - 188
  • [49] Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation
    Liu, Shiqi
    Zhao, Ruqian
    Zang, Yuqin
    Huang, Pengzhu
    Zhang, Qiaoling
    Fan, Xiangqin
    Bai, Junyi
    Zheng, Xingyu
    Zhao, Shuangshuang
    Kuai, Dan
    Gao, Chao
    Wang, Yingmei
    Xue, Fengxia
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, : 3147 - 3160
  • [50] Enhancement of jaw bone regeneration via ERK1/2 activation using dedifferentiated fat cells
    Fujisaki, Seiichi
    Kajiya, Hiroshi
    Yanagi, Tsukasa
    Maeshiba, Munehisa
    Kakura, Kae
    Kido, Hirofumi
    Ohno, Jun
    CYTOTHERAPY, 2021, 23 (07) : 608 - 616
12345